Next 10 |
home / stock / cdmo / cdmo articles
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ:CDMO) investors who suffered substantial lo...
SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securitie...
NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Avid Bioservices, Inc. ("Avid" or ...
SAN FRANCISCO, March 14, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ:CDMO) investors who suffered substantial lo...
SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ:CDMO) investors who suffered substantial lo...
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigat...
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) -- The Po...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Thursday. The Dow traded up 0.34% to 38,7...
Wednesday, Avid Bioservices Inc (NASDAQ:CDMO) reported preliminary revenues for the third quarter of fiscal 2024 of $33.8 million, repres...
News, Short Squeeze, Breakout and More Instantly...
Avid Bioservices Inc. Company Name:
CDMO Stock Symbol:
NASDAQ Market:
Avid Bioservices Inc. Website:
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ:CDMO) investors who suffered substantial lo...
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ: CDMO) investors who suffered substantial losses to submit your losses now . Avid Bioservices, Inc. (CDMO) Investigation: Avid Bioservices, Inc. (CDMO) finds itself embro...
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion Program with Grand Opening of Cell and Gene Therapy Manufacturing Facility in January 20...